{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.89A>T",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "A",
            "alt": "T",
            "position": "89"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P"
        },
        {
          "HGVS": "NM_001126112.3:c.158A>T",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "A",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0000518"
  },
  "Experiment Method": [
    {
      "Assay Method": "Microarray analysis",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Neuroblastoma cell lines",
        "Description": "Neuroblastoma cell lines transfected with wild-type or mutant alpha-synuclein (A30P or A53T)."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.89A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Downregulation of target genes",
          "Result Description": "Wild-type alpha-synuclein caused downregulation of genes (e.g., SNCA, PARK2), while A30P/A53T mutants did not."
        },
        {
          "Variant": "NM_001126112.3:c.158A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Downregulation of target genes",
          "Result Description": "Wild-type alpha-synuclein caused downregulation of genes (e.g., SNCA, PARK2), while A30P/A53T mutants did not."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Expression levels within baseline range (custom standard).",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Expression levels deviating from baseline by ≥20% (custom standard).",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Quantitative RT-PCR",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Neuroblastoma cell lines",
        "Description": "Neuroblastoma cell lines transfected with wild-type or mutant alpha-synuclein (A30P or A53T)."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.89A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Downregulation of target genes",
          "Result Description": "Wild-type alpha-synuclein caused downregulation of mRNA (e.g., SNCA, PARK2), while A30P/A53T mutants did not."
        },
        {
          "Variant": "NM_001126112.3:c.158A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Downregulation of target genes",
          "Result Description": "Wild-type alpha-synuclein caused downregulation of mRNA (e.g., SNCA, PARK2), while A30P/A53T mutants did not."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Expression levels within baseline range (custom standard).",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Expression levels deviating from baseline by ≥20% (custom standard).",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Western blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Neuroblastoma cell lines",
        "Description": "Neuroblastoma cell lines transfected with wild-type or mutant alpha-synuclein (A30P or A53T)."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.89A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Downregulation of target proteins",
          "Result Description": "Wild-type alpha-synuclein caused reduced protein levels (e.g., SNCA, PARK2), while A30P/A53T mutants did not."
        },
        {
          "Variant": "NM_001126112.3:c.158A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Downregulation of target proteins",
          "Result Description": "Wild-type alpha-synuclein caused reduced protein levels (e.g., SNCA, PARK2), while A30P/A53T mutants did not."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D.",
        "Description": "Not explicitly mentioned in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Expression levels within baseline range (custom standard).",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Expression levels deviating from baseline by ≥20% (custom standard).",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}